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Purpose: To determine the diagnostic accuracy of targeted electrical impedance imaging
in characterizing breast lesions, and to evaluate whether lesion size, depth and
histopathology affect the diagnosis.
Material and Methods: A total of 137 women with 145 lesions (79 malignant and 66
benign) found by palpation or mammography were prospectively enrolled in this study.
The patients were examined by means of clinical breast examination, mammography,
ultrasonography, and electrical impedance imaging with TransScan TS2000. A level of
suspicion (LOS) post-processing algorithm (v2.67) was used for TS2000 lesion
assessment. Imaging findings were correlated with cytologic (n554) and histologic
diagnoses (n591). Patients with benign lesions were followed up for a mean of 36
months.
Results: TS2000 showed a high sensitivity (86%) which did not differ significantly from
that of mammography (87%) and ultrasonography (US) (75%). The specificity of TS2000
(49%) was significantly lower compared to mammography (97%, Pv0.0001) and US
(100%, Pv0.0001). The additive use of TS2000 to mammography and US yielded no
significant increase in sensitivity (97%), but the decrease in specificity was significant
(46%, Pv0.0001). Diagnostic effectiveness of TS2000 (Az50.68), as measured by the
area under the ROC curve, was significantly lower than for mammography (Az50.93,
Pv0.0001) and for US (Az50.91, Pv0.0001). When using TS2000 in addition to
mammography and US (Az50.86), a significant impairment was found (P50.0003).
Conclusion: The role of targeted electrical impedance imaging as an adjunct to
mammography and ultrasonography in the diagnosis of breast lesions is not justified
by the result of this study.
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Various attempts have been made to improve the
diagnostic efficiency of conventional breast imaging
methods by introducing novel techniques. Methods
based on the detection of electrophysiological
properties of breast tissue are currently under
development. One method is to collect and analyze
differences in electrical potential at the skin level
caused by neoplastic activity (4). Other approaches
focus on measuring conductivity and capacitance of
tissues using multiple frequencies of alternating
electric current (2,3,9). The principle behind multi-
frequency impedance imaging is not a new discov-
ery. In 1926, FRICKE & MORSE found that
capacitance of tumors differed significantly from
that of normal or benign breast tissues (5).
Although there is a long-known underlying scien-
tific basis, it took more than 60 years before an
electrical impedance imaging system was con-
structed (8,15).
TransScan TS2000 (TransScan Medical, Migdal
Ha’Emek, Israel was distributed by Siemens-Elema,
Solna, Sweden until 2001) has been introduced as
the first commercial product that uses impedance
technology (2). Special attention has been directed
to the development of this new modality because it
is a generally safe, non-invasive, radiation-free, and
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low-cost solution. TS2000 produces a real-time skin-
level impedance map of the area under examination
and displays the data on gray-scale images. Highly
conductive areas and inhomogeneities in impedance
maps are found to be strongly associated with breast
malignancies. Several clinical trials have been
conducted to test this modality, and these have
suggested that TS2000 has adjunctive value to
conventional imaging methods, especially in
mammographically suspicious lesions (6,10–12).
However, other studies have not confirmed these
findings (13,19).
The aims of our study were to determine the
diagnostic accuracy of the LOS (level of suspicion)
analysis algorithm of targeted mode TS2000 in
characterizing breast lesions compared to mammo-
graphy and ultrasound, and to evaluate whether
lesion size, depth and histopathology affect the
diagnosis established by impedance imaging.
Material and Methods
Patients
All patients gave informed consent to participation
and the local ethics committee approved the study.
A total of 137 women (median age 56 years; range
33–92 years) with 145 lesions were prospectively
enrolled in the study. Eligible patients were required
to have had a breast abnormality found either by
clinical breast examination (CBE) or mammogra-
phy. Primary exclusion criteria were an implanted
cardiac pacemaker, pregnancy, previous chemother-
apy, radiation therapy, or breast surgery on the side
to be examined. The following procedures were
included in the diagnostic work-up: CBE, mammo-
graphy, ultrasonography (US), and electrical impe-
dance imaging. The imaging findings were
correlated with the results of fine needle aspiration
cytology (FNAC, n554), core needle biopsy (n55),
or histopathologic analysis of the surgically excised
specimen (n586). Patients with benign lesions were
followed up for a mean period of 36 months. All
patients in whom malignant breast disease devel-
oped during the follow-up period were excluded
from the analysis. Of the 64 patients with 66 benign
lesions, there were 28 (44%) who had a breast
complaint but were diagnosed as benign during the
follow-up; 36 (56%) remained asymptomatic. The
World Health Organization (WHO) classification
was used for typing histologic tumor samples.
Histologic grade of invasive carcinomas was
assessed using the Elston-Ellis grading system.
Lesion size was determined either by the
histopathologic or ultrasound examination. Depth
was measured from the skin level to the upper
border of the lesions by ultrasound.
Mammography
Mammography was performed with dedicated equip-
ment (Mammomat 3000; Siemens, Solna, Sweden/
Senographe DMR; G.E. Medical Systems,
Milwaukee, Wisc., USA). The Kodak Min-R2 film-
screen cassette system was used with Kodak Min-RE
films (Eastman Kodak, Rochester, N.Y., USA).
Films were processed in a Kodak X-omat 300
daylight machine using extended cycle processing.
Each breast was examined in three standard views
(cranio-caudal, mediolateral oblique, and laterome-
dial), and additional views (spot and/or direct
magnification) were taken when it was necessary
for better visualization. Mammographic findings
were categorized on the basis of a 5-point rating
scale describing the degree of suspicion for malignant
disease. These five groups were defined according to
the ACR/BI-RADS (Breast Imaging Reporting and
Data System of the American College of Radiology)
assessment scoring system (1).
Mammograms were read and evaluated in con-
sensus by three experienced radiologists. Observers
were blinded to other imaging methods, but were
aware of the result of CBE.
Ultrasonography
The US examinations were performed with an
Acuson Aspen ultrasound system (Acuson Inc.,
Mountain View, Calif., USA) using the L7 (5–
10 MHz) and L10 (6–11 MHz) linear transducers.
Gray-scale US evaluation of the indicated breast
and axilla was performed. Spiculated lesions,
angular margins, marked hypoechogenicity and
back shadowing were considered as signs of
malignancy. Features associated with benign lesions
were the following: intense hyperechogenicity, echo-
genic pseudocapsule, and ellipsoid shape (18).
Lesions identified by US were scored on a level of
suspicion scale from 1 to 5.
US was performed with the knowledge of the
clinical and mammographic findings and analyzed
in consensus by three radiologists.
Electrical impedance imaging
Electrical impedance measurements were carried out
using the TS2000 imaging device. The main
components of the TS2000 system are as follows: a
PC workstation with a connected laser printer and
data transfer devices, reference electrode, and
scanning probes. The sensing area of the probes
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contains a matrix of electrodes (large probe, 16616;
small probe, 868). The reference electrode is the
source of biocompatible alternating electric current
(0.1–2.5 V, 5 mA). Patients hold this electrode in
the hand contralateral to the side being examined
while lying in the supine position. A thin layer of
conducting gel is applied as the contact medium
between the skin and the sensors of the probe.
TS2000 produces real time conductivity and capa-
citance gray-scale images using 7 different frequen-
cies for measurements: 1, 2, 10, 20, 30, 40, and
50 kHz.
TS2000 examinations were performed with the
full knowledge of the patient’s history and the
findings of CBE, mammography, and US. All breast
lesions were scanned using the targeted mode. The
region of the nipple on the indicated side was
required to be recorded first. Then each palpable
and/or mammographically detected lesion was
recorded at its known location. External objects
like air bubbles in the conductive gel, scars, moles,
pimples, scratches, and other skin lesions may alter
the conductivity and capacitance maps. These
artifacts were identified and excluded from the
analysis.
For lesion assessment, a post-processing algo-
rithm (LOS algorithm, software version 2.67) was
used which operates by displaying the result on a 5-
level scoring scale (15normal, 25benign, 35prob-
ably benign, 45suspicious of malignancy, 55highly
suspicious of malignancy). The LOS algorithm uses
conductivity and capacitance data measured in the
sector of concern, as well as in the nipple area. The
algorithm is also influenced by patient age, as
the system uses different algorithms for different age
groups. TS2000 finding was considered as malignant
if a red frame appeared around the recorded sector
(LOS 4 or 5). This LOS algorithm was compared to
the assessment method used in the previous versions
of TransScan (spot method), where the presence of a
bright (white) spot on the recorded conductivity
image was interpreted as a suspicious finding.
Statistical methods
Sensitivity, specificity, percent correct diagnostic
accuracy, positive (PPV) and negative (NPV)
predictive values were calculated using standard
formulae. The results of the combined methods
were defined as the highest score obtained with
either method. Empiric receiver operating charac-
teristic (ROC) curves were drawn, and the diag-
nostic accuracy of each imaging method was
determined by calculating the area under the
ROC curve (Az). The method of HANLEY &
MCNEIL was used to test paired data for significant
difference (7).
The comparison of two percentages was per-
formed using McNemar, Pearson’s x2, or Fisher’s
exact test when appropriate. Spearman’s correlation
test was performed for comparison of ordinal
variables. The Mann-Whitney U test was used to
evaluate the differences between two groups of non-
parametric quantitative variables. Statistical calcu-
lations were carried out using SPSS 10.0 for
Windows (SPSS Inc., Chicago, Ill., USA).
Results
Cytologic and histopathologic examinations
revealed 79 (55%) malignant and 66 (45%) benign
lesions. Of the 79 histopathologically verified
malignant lesions, there were 6 (8%) in situ and 73
(92%) invasive cancers. Seventeen (24%) grade I, 37
(53%) grade II, and 16 (23%) grade III invasive
carcinomas were identified. Grading information
was not available in three cases. The summary of
cytologic and histologic diagnoses is given in
Table 1.
There were 100 (69%) palpable and 45 (31%) non-
palpable lesions. The mean lesion size was
22.4 mm¡14 (SD); range 5–74 mm (size informa-
tion was available for 111 lesions). There were 22
(20%) lesions smaller than or equal to 10 mm, 42
(38%) lesions in the range 11–20 mm, and 47 (42%)
lesions larger than 20 mm. The mean depth was
9.3 mm¡4 (SD) and ranged from 1 to 20 mm.
Diagnostic accuracy
The summary of diagnostic indices for each imaging
method is given in Table 2. TS2000 showed a high
Table 1. The breakdown of cytologic (n554, 37%) and histologic
(n591, 63%) diagnoses of 145 breast abnormalities in 137 patients
examined by TransScan TS2000 electrical impedance scanner
Malignant lesions (n579)
Invasive ductal cancer 57
Invasive lobular cancer 8
Ductal carcinoma in situ 6
Invasive tubular cancer 5
Invasive mucinous cancer 3
Benign lesions (n566)
Negative FNAC, without histologic diagnosis 48
Simple cyst 4
Benign core biopsy 3
Fibroadenoma 3
Abscess 2
Sclerosing adenosis 2
Atypic hyperplasia 1
Chronic mastitis 1
Fibrocystic disease 1
Fibrosis 1
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sensitivity, which did not differ significantly from that
of mammography (P51) and US (P50.064). The
specificity of TS2000 was significantly lower com-
pared to mammography (Pv0.0001). The additive
use of TS2000 to mammography and US yielded no
significant increase in sensitivity (P50.125), but the
decrease in specificity was significant (Pv0.0001).
The percent correct diagnostic accuracy of TS2000
was also significantly lower than that of mammo-
graphy (Pv0.0001) and US (Pv0.0001), and adding
TS2000 to the basic imaging methods resulted in a
significantly lower accuracy (Pv0.0001).
Excluding mammographically normal or benign
(BI-RADS I and II) cases (n537) resulted in lower
values of specificity: 94% (30/32) for mammogra-
phy, 38% (12/32) for TS2000, 94% (30/32) for the
combination of mammography and US, and 31%
(10/32) for the combination of all methods.
Diagnostic accuracies calculated by ROC analysis
were as follows: Az50.93 (95% CI: 0.89, 0.98) for
mammography, Az50.91 (95% CI: 0.86, 0.96) for
US, Az50.68 (95% CI: 0.59, 0.77) for TS2000,
Az50.95 (95% CI: 0.91, 0.99) for the combination of
mammography and US, and Az50.86 (95% CI:
0.80, 0.92) for the combination of mammography,
US and TS2000. Diagnostic performance of TS2000
was significantly lower than that of mammography
(Pv0.0001) and US (Pv0.0001), and using TS2000
as an adjunct to mammography and US the
diagnostic accuracy of the combination significantly
decreased (P50.0003).
Figure 1 shows the ROC curves of the single
methods of mammography, US, and TS2000.
Figure 2 illustrates a small malignant breast tumor
as shown by mammography, US, and TS2000. A false-
positive finding by TS2000 is demonstrated in Fig. 3.
False-negative results of TS2000
Of the 57 invasive ductal cancers, 6 (11%) were
classified as benign by TS2000. There was 1 (13%)
false-negative finding of the 8 invasive lobular
cancers, and also 1 (20%) lesion of the 5 invasive
tubular cancers coded as benign. Two (67%) of the 3
invasive mucinous cancers were false-negatives. One
(17%) of the 6 ductal carcinomas in situ (DCIS) was
classified as benign.
False-positive results of TS2000
Three (75%) of the 4 simple cysts, 1/2 (50%) abscess,
1/2 (50%) sclerosing adenosis, and 1/1 fibrosis were
indicated as malignant by TS2000. Twenty (39%) of
the 51 otherwise non-defined benign or normal
findings (48 negative FNAC and 3 negative core
biopsy) were false-positive on TS2000.
Comparison of the LOS algorithm and the spot
method
The spot method (white spots on the conductivity
images were considered as positive findings) had a
sensitivity of 77% (61/79), specificity of 79% (52/66),
diagnostic accuracy of 78% (113/145), PPV was 77%
(61/79) and the NPV was 79% (52/66). The spot
method showed a significantly higher specificity
(P50.0003) and diagnostic accuracy (Pv0.0001)
compared to the diagnostic performance of the LOS
algorithm, but there was no significant difference in
sensitivity (P50.092).
Effect of lesion characteristics
To measure the effect of lesion size and depth on
diagnostic performance, the groups of correctly and
incorrectly diagnosed cases were compared. There
was no significant difference in size and depth when
looking at the percent correct diagnostic accuracy
(P50.59 and P50.15, respectively), sensitivity
(P50.87 and P50.68, respectively), and specificity
(P50.82 and P50.57, respectively).
Sensitivity, specificity, and diagnostic accuracy
were 93% (14/15), 29% (2/7), and 73% (16/22) for
lesions (10 mm, and 86% (24/28), 50% (7/14), and
74% (31/42) for lesions 11–20 mm, and 85% (29/34),
39% (5/13), and 72% (34/47) for lesions w20 mm,
respectively. There was no significant difference in
diagnostic indices between these size groups (for
difference in sensitivity: P50.46, between lesions
Table 2. Diagnostic accuracy of mammography (MG), ultrasonography (US), TransScan 2000* (TS) and the combination of methods in 145
palpable or mammographically suspicious breast abnormalities (79 malignant and 66 benign)
MG US TS MG+US US+TS US+MG+TS
Sensitivity (%) 87 (69/79) 75 (57/79) 86 (68/79) 92 (73/79) 92 (73/79) 97 (77/79)
Specificity (%) 97 (64/66) 100 (66/66) 49 (32/66) 97 (64/66) 49 (32/66) 46 (30/66)
Diagnostic
accuracy (%)
92 (133/145) 86 (125/145) 69 (100/145) 95 (137/145) 72 (105/145) 74 (107/145)
PPV (%) 97 (69/71) 100 (59/59) 67 (68/102) 97 (73/75) 68 (73/107) 68 (77/113)
NPV (%) 87 (64/74) 77 (66/86) 74 (32/43) 91 (64/70) 84 (32/38) 94 (30/32)
*In targeted examination mode, using the LOS analysis algorithm.
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(10 mm and 11–20 mm, and P50.39, between
lesions ( 10 mm and w20 mm).
There was no significant difference in sensitivity
between in situ and invasive lesions (P51). No
significant correlation was noted between histologic
grade and TS2000 findings (P50.89).
Discussion
The results of our study show that targeted TS2000
examination could not provide significant adjunc-
tive diagnostic aid to mammography and US.
TS2000 showed a considerably high sensitivity, but
at a cost of reduced specificity (approximately half
of the benign lesions were false-positives).
Furthermore, this high sensitivity does not differ
significantly from that of mammography, US, and
even from the classical (spot versus no spot) TS2000
assessment method. On the other hand, examining
the specificity and diagnostic accuracy, significant
impairment was found as compared to mammogra-
phy and US. Since the percent correct diagnostic
accuracy is highly dependent on the prevalence, the
diagnostic performance as shown by area under the
ROC curve was also evaluated. ROC analysis
revealed highly significant differences in diagnostic
effectiveness between TS2000 and the conventional
breast imaging modalities.
Fig. 1. Receiver operating characteristic (ROC) curves of mammography (MG), ultrasonography (US), and TransScan TS2000 electrical
impedance scanner (LOS) in 145 palpable or mammographically suspicious breast abnormalities (79 malignant and 66 benign).
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Fig. 2. Histopathologically proved 10-mm-large invasive ductal carcinoma in a 57-year-old woman’s right breast. A. Mammography
revealed a suspicious lesion (arrow). B. Ultrasonography showed a small hypoechoic lesion with back shadowing. C. Targeted electrical
impedance imaging showed a bright spot on conductivity images which was classified as suspicious for malignancy (LOS 4). Note that the first
sector is the nipple.
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Fig. 3. A 46-year-old woman referred to mammography due to a suspicious palpable lump in her right breast. A. Mammography showed
several circumscribed lesions (arrow) which were classified as probably benign. B. Ultrasonography showed an anechoic lesion with pronounced
acoustic enhancement at the location of the palpable lump, and described as a simple cyst. C. This image represents a false-positive case.
TransScan showed marked inhomogeneity in conductivity maps; the finding was classified as suspicious for malignancy by the LOS algorithm.
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There is controversy in the scientific literature
about the diagnostic value of targeted electrical
impedance scanning. A wide variety of diagnostic
indices has been reported in different studies, the
sensitivity ranging from 62% to 93% and specificity
from 50% to 82% (6,10–13, 19). However, most of
the studies emphasized the high sensitivity of
TS2000 and suggested that it could be used as a
complementary tool to mammography and US in
diagnosing breast cancer (10–12). Moreover, one
study claimed that the area under the ROC curve
was significantly higher for TS2000 than other
imaging methods (6). In contrast to these reports,
there are two studies that found mediocre diagnostic
effectiveness of impedance imaging (13,19). Our
study supports the high rate of false-positive
findings of TS2000 continuing to be an issue, and
this limitation prevents wide clinical use of the
technology. Although the high sensitivity of TS2000
could be confirmed, no additive value for conven-
tional imaging was proved.
According to the established criteria described
in preliminary studies on electrical impedance
imaging (6,12), each spot representing high con-
ductivity or capacitance, which is not caused by an
artifact, should be interpreted as suspicious for
malignancy. The LOS post-processing algorithm
provided by the new versions of TS2000 was
developed to replace the old assessment approach.
In our study, this spot method showed significantly
higher diagnostic accuracy and specificity than the
LOS software. Our findings indicate that this
advanced setup does not represent real diagnostic
improvement, and the apparently high sensitivity of
the LOS method could only be achieved at the cost
of decreased specificity.
When evaluating a diagnostic test, the method of
selecting patients might be a cause that accounts for
differences in results among studies. In this study,
besides mammographically equivocal or highly
suspicious findings (BI-RADS III-V), mammogra-
phically normal or benign (BI RADS I and II) cases
were also included, but only those which turned out
to be suspicious at physical examination. One can
explain our results by the relatively high proportion
of benign or negative mammograms compared to
other studies. In order to clarify how selection
criteria affect diagnostic accuracy in this case, the
relevant diagnostic indices were also calculated for
the subgroup of mammographically suspicious
lesions (BI-RADS III-V). The results show that
specificities decreased for all methods, consequently
TS2000 performs better in terms of specificity
among mammographically negative or benign cases,
and patient selection is unlikely to be the source of
the poor diagnostic accuracy.
However, although the small number of in situ
lesions included in this study probably prevents a
thorough comparison with invasive disease, we
found that TS2000 had similar sensitivity in invasive
and in situ cancers. This finding is in agreement with
one study (12), although another group reported on
significantly lower detection rates for DCIS than
invasive lesions (10). The literature is consistent in
reporting the highest sensitivity for ductal invasive
cancers, but there is a little evidence of the special
types of breast cancer. In our study, it was
surprising that only 1 of the 3 mucinous cancers
was identified as malignant by TS2000, achieving
the lowest sensitivity of 33%. Larger sample size and
further investigations of mucinous cancer are
needed if any conclusions are to be drawn for this
histologic group.
With regard to specificity, no correlation was
found with histologic type or any other factors. The
proportions of false-positive findings among differ-
ent histologic types of benign lesions are found to be
similar in our study. Where the principles of
electrical impedance imaging are concerned, we
can assume that proliferative benign disease is
responsible for most of the false-positive results,
although ours and previous investigations could not
explore such an association. Another explanation
that has been suggested is that hormonal status of
the patients may influence the electrical properties
of breast tissues. Recent studies have shown that
false-positive findings are common in young pre-
menopausal women (12,14), and estrogen activity in
breast tissue affects the electrical impedance pattern
(16). Since the LOS software algorithm uses not
only measured conductivity/capacitance data, but
also patient age, and selects the appropriate
calculation method according to different age
groups, the effect of patient’s age and hormonal
status was not investigated in this study.
Other factors hypothesized as altering the detec-
tion of impedance signals include lesion size and
depth measured from the surface. A simulation
study has shown that increasing object size and
depth decreases its detectability by impedance
imaging (17). Another study found that TS2000
showed the highest sensitivity in detecting small
lesions (11–20 mm) compared to large lesions
(w20 mm) (19). In our study, the highest detection
rate was found in the group of smallest lesions
( 10 mm): 14 of the 15 malignant lesions in this
group were classified as suspicious by TS2000,
although the difference in sensitivity was not
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significant. In addition, the correctly or incorrectly
diagnosed lesions did not differ in lesion size or
depth in this study. It should be noted that different
types and histologic grades of invasive cancers did
not differ in electrical properties, our results thus
suggesting that electrical impedance maps do not
carry prognostic information.
In conclusion, the role of targeted electrical
impedance imaging as an adjunct to mammography
and ultrasonography in diagnosing breast lesions is
not justified by the results of this study. Targeted
mode TS2000 showed high sensitivity, but limitingly
low specificity compared to conventional imaging
techniques. The theory behind electrical impedance
imaging is promising, but TransScan TS2000 must
undergo further developments before it is used in a
broad clinical application.
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